Will PI3K pathway inhibitors be effective as single agents in patients with cancer?

Title
Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
Authors
Keywords
-
Journal
Oncotarget
Volume 2, Issue 12, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-17
DOI
10.18632/oncotarget.409

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started